LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 33.80 | 21.74 | 2246 | 2381 | 0.9431 | 0.9828 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 33.80 | 21.74 | 472 | 2381 | 0.1982 | 0.5750 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 33.80 | 21.74 | 2167 | 2381 | 0.9099 | 0.9723 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 35.77 | 21.74 | 2344 | 2602 | 0.9006 | 0.9699 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 35.77 | 21.74 | 2462 | 2602 | 0.9461 | 0.9840 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 35.77 | 21.74 | 724 | 2602 | 0.2782 | 0.6616 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 35.77 | 21.74 | 2356 | 2602 | 0.9052 | 0.9713 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 37.74 | 21.74 | 2609 | 2828 | 0.9225 | 0.9772 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 37.74 | 21.74 | 2661 | 2828 | 0.9409 | 0.9827 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 37.74 | 21.74 | 1224 | 2828 | 0.4328 | 0.7752 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 37.74 | 21.74 | 2542 | 2828 | 0.8987 | 0.9698 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 39.71 | 21.74 | 2823 | 3084 | 0.9153 | 0.9754 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 39.71 | 21.74 | 2876 | 3084 | 0.9325 | 0.9806 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 39.71 | 21.74 | 2078 | 3084 | 0.6738 | 0.8925 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 39.71 | 21.74 | 2777 | 3084 | 0.9004 | 0.9709 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 41.68 | 21.74 | 3077 | 3418 | 0.9000 | 0.9713 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 41.68 | 21.74 | 3144 | 3418 | 0.9196 | 0.9772 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 41.68 | 21.74 | 2841 | 3418 | 0.8310 | 0.9499 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 41.68 | 21.74 | 3064 | 3418 | 0.8962 | 0.9702 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 43.65 | 21.74 | 3400 | 3754 | 0.9057 | 0.9735 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 43.65 | 21.74 | 3434 | 3754 | 0.9147 | 0.9762 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 43.65 | 21.74 | 3290 | 3754 | 0.8764 | 0.9648 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 43.65 | 21.74 | 3399 | 3754 | 0.9054 | 0.9734 | MN20160310_N01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 45.62 | 21.74 | 3754 | 4150 | 0.9044 | 0.9737 | MN20160310_N01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 45.62 | 21.74 | 3778 | 4150 | 0.9102 | 0.9753 | MN20160310_N01 | C19 |